These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 3283770

  • 1. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
    Sternberg CN, Yagoda A, Scher HI, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Bosl G, Watson RC, Hollander PS.
    Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.
    Sternberg CN.
    Prog Clin Biol Res; 1990; 353():143-52. PubMed ID: 2217412
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Watson RC, Hollander PS, Fair WR.
    Prog Clin Biol Res; 1988; 260():481-5. PubMed ID: 3283768
    [No Abstract] [Full Text] [Related]

  • 8. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
    Simon SD, Srougi M.
    Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ.
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
    Fair WR, Scher H, Herr H, Morse M, Sogani P, Bosi G, Dershaw D, Reuter V, Curley T.
    Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy for advanced urothelial cancer.
    Yagoda A.
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract] [Full Text] [Related]

  • 16. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO, Coussens D.
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Organ conservation in deeply invasive bladder cancer.
    Fair WR.
    Prog Clin Biol Res; 1991 Feb; 370():119-26. PubMed ID: 1924440
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.